Note: This document contains side effect information about ixekizumab. Some dosage forms listed on this page may not apply to the brand name Taltz.

Applies to ixekizumab: parenteral injection.

Side effects include:

Injection site reactions, upper respiratory tract infections (e.g., nasopharyngitis, rhinovirus infection), nausea, tinea infections.

For Healthcare Professionals

Applies to ixekizumab: subcutaneous solution.

Dermatologic

Common (1% to 10%): Urticaria

Uncommon (0.1% to 1%): Angioedema^[Ref]

Gastrointestinal

Common (1% to 10%): Nausea

Uncommon (0.1% to 1%): Oral candidiasis, inflammatory bowel disease^[Ref]

Hematologic

Very common (10% or more): Neutropenia (11%)

Common (1% to 10%): Thrombocytopenia^[Ref]

Immunologic

Very common (10% or more): Infections (26%), immunogenicity (22%)

Common (1% to 10%): Tinea infections, influenza

Uncommon (0.1% to 1%): Serious infections^[Ref]

Local

Very common (10% or more): Injection site reactions (17%), erythema, pain^[Ref]

Ocular

Common (1% to 10%): Conjunctivitis^[Ref]

Respiratory

Very common (10% or more): Upper respiratory tract infections (including nasopharyngitis and rhinovirus infection) (14%)

Uncommon (0.1% to 1%): Rhinitis^[Ref]

Hypersensitivity

Frequency not reported: Serious hypersensitivity reactions (e.g., anaphylaxis, angioedema, urticaria)^[Ref]